Literature DB >> 20032380

Activation of human monocyte-derived dendritic cells in vitro by Thymax, a gross thymic extract.

Mamdooh Ghoneum1, Yoshikazu Seto, Sudhanshu Agrawal.   

Abstract

BACKGROUND: We have recently demonstrated that Thymax, a gross thymic extract, induces an apoptotic effect against human breast cancer cells. In this study, the ability of Thymax to activate human dendritic cells (DCs) and the DC-directed T-cell response was examined in an in vitro culture model of peripheral blood mononuclear cells.
MATERIALS AND METHODS: The level of costimulatory molecules (CD40, CD80, CD83, CD86) and T-cell proliferation were analyzed by flow cytometry. Cytokine secretion was measured by ELISA.
RESULTS: Thymax activated DCs to secrete interleukin (IL)-12p40 and IL-6 cytokines and inhibited IL-10 production. Additionally, Thymax caused the up-regulation of CD80 and CD86 in DCs, leading to an increase in CD4(+) T-cells, which subsequently induced secretion of interferon-gamma (IFN-gamma).
CONCLUSION: Taken together, the data showed that Thymax activated DCs and, consequently, Th1 cells. Thus, Thymax is an immune-activating compound that needs to be evaluated extensively for its possible therapeutic properties.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032380

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

1.  Thymax, a gross thymic extract, exerts cell cycle arrest and apoptosis in Ehrlich ascites carcinoma in vivo.

Authors:  Nariman K Badr El-Din; Azza I Othman; Maggie E Amer; Mamdooh Ghoneum
Journal:  Heliyon       Date:  2022-03-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.